Related Experiment Video
Updated: Aug 15, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Human piebaldism: six novel mutations of the proto-oncogene KIT
Petros Syrris1, Kirsten Heathcote, Romeo Carrozzo
1Medical Genetics Unit, St George's Hospital Medical School, London, United Kingdom. psyrris@sghms.ac.uk
Abstract:
Human piebaldism is a rare autosomal dominant disorder that comprises congenital patchy depigmentation of the scalp, forehead, trunk and limbs. It is caused by mutations in the cell-surface receptor tyrosine kinase gene (KIT, also c-kit). We screened three families and three isolated cases of piebaldism from different countries for mutations in the KIT gene using automated sequencing methods. We report six novel KIT point mutations: three missense (C788R, W835R, P869S) at highly conserved amino acid sites; one nonsense (Q347X) that results in termination of translation of the KIT gene in exon 6; and two splice site nucleotide substitutions (IVS13+2T>G, IVS17-1G>A) that are predicted to impair normal splicing. These mutations were not detected in over 100 normal individuals and are likely to be the cause of piebaldism in our subjects.
Insights
Six novel mutations in the KIT gene cause human piebaldism, a rare genetic disorder characterized by congenital depigmentation. These KIT gene mutations disrupt normal cell signaling, leading to the observed skin pigmentation patterns.
Area of Science:
- Genetics
- Dermatology
- Molecular Biology
Background:
- Human piebaldism is a rare autosomal dominant disorder.
- It is characterized by congenital patchy depigmentation affecting the scalp, forehead, trunk, and limbs.
- The disorder is linked to mutations in the KIT gene, which encodes a cell-surface receptor tyrosine kinase.
Purpose of the Study:
- To identify mutations in the KIT gene in families and individuals with piebaldism.
- To investigate the genetic basis of human piebaldism.
Main Methods:
- Screening of the KIT gene for mutations using automated sequencing methods.
- Analysis of three families and three isolated cases of piebaldism from different countries.
Main Results:
- Identification of six novel KIT point mutations: three missense (C788R, W835R, P869S), one nonsense (Q347X), and two splice site mutations (IVS13+2T>G, IVS17-1G>A).
- The identified mutations were not found in over 100 normal individuals.
- The mutations are located at highly conserved amino acid sites or are predicted to impair normal splicing.
Conclusions:
- The identified novel KIT gene mutations are likely the cause of piebaldism in the studied subjects.
- These findings contribute to understanding the molecular mechanisms underlying human piebaldism.
Related Concept Videos
Pleiotropy
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a superfamily...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

